- Home
- QSI vs CRMD Comparison
QSI vs CRMD Comparison
Compare QSI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QSI | CRMD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 943.9M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | QSI | CRMD |
|---|---|---|
| Price | $1.10 | $12.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $2.63 | ★ $17.43 |
| AVG Volume (30 Days) | ★ 4.7M | 2.7M |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | $3,177,000.00 | ★ $214,303,672.00 |
| Revenue This Year | N/A | $627.89 |
| Revenue Next Year | $159.68 | $40.95 |
| P/E Ratio | ★ N/A | $5.54 |
| Revenue Growth | 40.20 | ★ 1647.67 |
| 52 Week Low | $0.95 | $5.60 |
| 52 Week High | $5.77 | $17.43 |
Technical Indicators
Market Signals| Indicator | QSI | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 32.58 | 56.75 |
| Support Level | $1.20 | $11.78 |
| Resistance Level | $1.33 | $13.02 |
| Average True Range (ATR) | 0.09 | 0.45 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 4.17 | 52.02 |
Price Performance
Historical ComparisonAbout QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.